Suppr超能文献

在内肽酶溶葡萄球菌素和阳离子肽蛙皮抗菌肽联合作用下,对金黄色葡萄球菌有强效的协同抑制作用。

Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin.

作者信息

Graham Shirley, Coote Peter J

机构信息

Centre for Biomolecular Sciences, School of Biology, University of St Andrews, The North Haugh, St Andrews KY16 9ST, UK.

出版信息

J Antimicrob Chemother. 2007 Apr;59(4):759-62. doi: 10.1093/jac/dkl539. Epub 2007 Feb 26.

Abstract

OBJECTIVES

Successful treatment of infections involving multiply drug-resistant methicillin-resistant Staphylococcus aureus (MRSA) is becoming increasingly difficult. In this work, we have investigated the potential of combining lysostaphin with cationic antimicrobial peptides to effectively inhibit Staphylococcus aureus.

METHODS

S. aureus strains were grown in 96-well plates in the presence of increasing concentrations of lysostaphin and the peptides ranalexin, dermaseptin S3(1-16) or magainin 2. Growth was determined visually after 48 h and the plates imaged, or by automated optical density readings in a plate reader. Susceptibility to the combination of lysostaphin and ranalexin was also determined by viable cell counts. The efficacy of combined lysostaphin and ranalexin on a solid surface was tested via disc diffusion assays.

RESULTS AND CONCLUSIONS

Combination of lysostaphin with ranalexin resulted in potent, synergistic inhibition of S. aureus MSSA476 and MRSA252. Synergistic inhibition was specific for lysostaphin-susceptible staphylococci and was not observed with clinical isolates of the Gram-negative Escherichia coli, or other Gram-positive organisms, such as Enterococcus faecalis. Lysostaphin was not specifically synergistic with ranalexin alone. Synergy was also observed with two other cationic antimicrobial peptides, magainin 2 and dermaseptin s3(1-16); although combination with ranalexin was most potent. Synergistic inhibition by ranalexin in combination with lysostaphin resulted in an enhanced bactericidal effect. Importantly, synergy between lysostaphin and ranalexin was also observed after impregnation and drying in filter paper discs that clearly inhibited growth of S. aureus on the surface of agar; a solid, porous matrix. Thus, the combination could represent a novel route to target wounds infected with drug-resistant MRSA via dressings impregnated with the two compounds.

摘要

目的

成功治疗涉及多重耐药耐甲氧西林金黄色葡萄球菌(MRSA)的感染正变得越来越困难。在这项研究中,我们研究了溶葡萄球菌酶与阳离子抗菌肽联合有效抑制金黄色葡萄球菌的潜力。

方法

金黄色葡萄球菌菌株在96孔板中培养,加入浓度递增的溶葡萄球菌酶以及肽类蛙皮素、皮蝇素S3(1 - 16)或马盖宁2。48小时后肉眼观察生长情况并对平板成像,或通过酶标仪自动读取光密度。还通过活菌计数法测定溶葡萄球菌酶和蛙皮素联合使用时的敏感性。通过纸片扩散法测试溶葡萄球菌酶和蛙皮素在固体表面的联合疗效。

结果与结论

溶葡萄球菌酶与蛙皮素联合对金黄色葡萄球菌MSSA476和MRSA252产生了强效的协同抑制作用。协同抑制作用对溶葡萄球菌酶敏感的葡萄球菌具有特异性,在革兰氏阴性大肠杆菌临床分离株或其他革兰氏阳性菌如粪肠球菌中未观察到。溶葡萄球菌酶单独与蛙皮素无特异性协同作用。与另外两种阳离子抗菌肽马盖宁2和皮蝇素S3(1 - 16)联合时也观察到协同作用;尽管与蛙皮素联合时效果最强。蛙皮素与溶葡萄球菌酶联合的协同抑制作用导致杀菌效果增强。重要的是,在滤纸圆片中浸渍并干燥后,溶葡萄球菌酶和蛙皮素之间也观察到协同作用,滤纸圆片在琼脂表面能明显抑制金黄色葡萄球菌生长;琼脂是一种固体多孔基质。因此,这种联合可能代表了一种通过浸渍有这两种化合物的敷料来靶向治疗耐药MRSA感染伤口的新途径。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验